These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 14598016)

  • 1. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC; Eckler JR; Rabin RA
    Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.
    Winter JC; Eckler JR; Rice KC; Rabin RA
    Pharmacol Biochem Behav; 2005 Jul; 81(3):694-700. PubMed ID: 15970314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.
    Winter JC
    Pharmacol Biochem Behav; 2008 Jan; 88(3):189-95. PubMed ID: 17936884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulus properties of LSD in C57BL/6 mice.
    Winter JC; Kieres AK; Zimmerman MD; Reissig CJ; Eckler JR; Ullrich T; Rice KC; Rabin RA; Richards JB
    Pharmacol Biochem Behav; 2005 Aug; 81(4):830-7. PubMed ID: 16005500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psilocybin-induced stimulus control in the rat.
    Winter JC; Rice KC; Amorosi DJ; Rabin RA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):472-80. PubMed ID: 17688928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S; Filipink RA; Bowen WD; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys.
    Jones HE; Li H; Balster RL
    Pharmacol Biochem Behav; 1998 Feb; 59(2):413-8. PubMed ID: 9476989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
    Benneyworth MA; Smith RL; Sanders-Bush E
    Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.
    Callahan PM; Appel JB
    Psychopharmacology (Berl); 1990; 100(1):13-8. PubMed ID: 2296621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):617-24. PubMed ID: 3211970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT1A receptor and the stimulus effects of LSD in the rat.
    Reissig CJ; Eckler JR; Rabin RA; Winter JC
    Psychopharmacology (Berl); 2005 Oct; 182(2):197-204. PubMed ID: 16025319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
    Swanson CJ; Schoepp DD
    J Pharmacol Exp Ther; 2002 Dec; 303(3):919-27. PubMed ID: 12438510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.
    Horiguchi M; Huang M; Meltzer HY
    Psychopharmacology (Berl); 2011 Sep; 217(1):13-24. PubMed ID: 21432027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD.
    Young R; Rosecrans JA; Glennon RA
    Life Sci; 1982 Jun; 30(24):2057-62. PubMed ID: 7109835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
    J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.
    Marona-Lewicka D; Chemel BR; Nichols DE
    Psychopharmacology (Berl); 2009 Apr; 203(2):265-77. PubMed ID: 18604600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.